Drug Profile
Hemoglobin crosfumaril
Alternative Names: DCLHb; Diaspirin crosslinked haemoglobin; Haemoglobin crosfumaril; HemAssist; Human haemoglobin - BaxterLatest Information Update: 10 Jul 2002
Price :
$50
*
At a glance
- Originator Baxter Healthcare Corporation
- Class
- Mechanism of Action Oxygen carriers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Septic shock
- Discontinued Hypovolaemia; Shock; Stroke; Vascular disorders